• "This is a whole new frontier of pharmaceutical research."

-John Maraganore, CEO of Alnylam Pharmaceuticals Inc., on microRNA

• "It speaks to where our head was at as a group, those many years ago."

-Michael Kaplitt, scientific co-founder of Neurologix Inc., on the progress of Celadon, which operates under his gene-therapy patent in heart research

• "Conventional wisdom suggests that 'you don't want to not follow the FDA's advice.'"

-Simos Simeonidis, analyst with Rodman and Renshaw, in a note explaining why ZioPharm Oncology Inc. is the exception to this rule